APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cancer Pain Therapeutics

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cancer Pain Therapeutics Industry Growth and Trends Forecast to 2032

22 December 2025108 pages

Choose your research edition.

Industry ResearchCancer Pain Therapeutics Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Cancer Pain Therapeutics Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Cancer Pain Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cancer Pain Therapeutics Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Cancer Pain Therapeutics Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Cancer Pain Therapeutics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cancer Pain Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cancer Pain Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cancer Pain Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cancer Pain Therapeutics include BioDelivery Science, Grunenthal Group, GW Pharmaceuticals, Meda Pharmaceuticals, Orexo, ProStrakan Group, WEX Pharmaceuticals, Eli-Lilly and Johnson＆Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cancer Pain Therapeutics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cancer Pain Therapeutics market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cancer Pain Therapeutics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cancer Pain Therapeutics.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cancer Pain Therapeutics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cancer Pain Therapeutics Market by Company

BioDelivery Science

Grunenthal Group

GW Pharmaceuticals

Meda Pharmaceuticals

Orexo

ProStrakan Group

WEX Pharmaceuticals

Eli-Lilly

Johnson＆Johnson

Sanofi

Teva pharmaceuticals

Cancer Pain Therapeutics Segment by Type

Opioids

Non-Steroidal Anti-Inflammatory Drugs

Others

Cancer Pain Therapeutics Segment by Application

Hormone Therapy

Chemotherapy

Radiotherapy

Paracetamol Treatment-Related Immunotherapy

Cancer Pain Therapeutics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cancer Pain Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cancer Pain Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cancer Pain Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cancer Pain Therapeutics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cancer Pain Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Opioids Table 2. Major Company of Non-Steroidal Anti-Inflammatory Drugs Table 3. Major Company of Others Table 4. Global Cancer Pain Therapeutics Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Cancer Pain Therapeutics Sales by Type (2021-2026) & (k units) Table 6. Global Cancer Pain Therapeutics Sales Market Share in Volume by Type (2021-2026) Table 7. Global Cancer Pain Therapeutics Sales by Type (2021-2026) & (US$ Million) Table 8. Global Cancer Pain Therapeutics Sales Market Share in Value by Type (2021-2026) Table 9. Global Cancer Pain Therapeutics Price by Type (2021-2026) & (US$/unit) Table 10. Global Cancer Pain Therapeutics Sales by Type (2027-2032) & (k units) Table 11. Global Cancer Pain Therapeutics Sales Market Share in Volume by Type (2027-2032) Table 12. Global Cancer Pain Therapeutics Sales by Type (2027-2032) & (US$ Million) Table 13. Global Cancer Pain Therapeutics Sales Market Share in Value by Type (2027-2032) Table 14. Global Cancer Pain Therapeutics Price by Type (2027-2032) & (US$/unit) Table 15. North America Cancer Pain Therapeutics Sales by Type (2021-2026) & (k units) Table 16. North America Cancer Pain Therapeutics Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Cancer Pain Therapeutics Sales by Type (2021-2026) & (k units) Table 18. Europe Cancer Pain Therapeutics Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Cancer Pain Therapeutics Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Cancer Pain Therapeutics Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Cancer Pain Therapeutics Sales by Type (2021-2026) & (k units) Table 22. Latin America Cancer Pain Therapeutics Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Cancer Pain Therapeutics Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Cancer Pain Therapeutics Sales by Type (2021-2026) & (US$ Million) Table 25. Cancer Pain Therapeutics Industry Trends Table 26. Cancer Pain Therapeutics Industry Drivers Table 27. Cancer Pain Therapeutics Industry Opportunities and Challenges Table 28. Cancer Pain Therapeutics Industry Restraints Table 29. Global Cancer Pain Therapeutics Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Cancer Pain Therapeutics Revenue Market Share by Company (2021-2026) Table 31. Global Cancer Pain Therapeutics Sales by Company (2021-2026) & (k units) Table 32. Global Cancer Pain Therapeutics Sales Share by Company (2021-2026) Table 33. Global Cancer Pain Therapeutics Market Price by Company (2021-2026) & (US$/unit) Table 34. Global Cancer Pain Therapeutics Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Cancer Pain Therapeutics Major Company Production Sites and Headquarters Table 36. Global Cancer Pain Therapeutics Company, Product Type & Application Table 37. Global Cancer Pain Therapeutics Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Cancer Pain Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Cancer Pain Therapeutics Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Cancer Pain Therapeutics Sales by Region (2021-2026) & (k units) Table 42. Global Cancer Pain Therapeutics Sales Market Share in Volume by Region (2021-2026) Table 43. Global Cancer Pain Therapeutics Sales by Region (2021-2026) & (US$ Million) Table 44. Global Cancer Pain Therapeutics Sales Market Share in Value by Region (2021-2026) Table 45. Global Cancer Pain Therapeutics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Global Cancer Pain Therapeutics Sales by Region (2027-2032) & (k units) Table 47. Global Cancer Pain Therapeutics Sales Market Share in Volume by Region (2027-2032) Table 48. Global Cancer Pain Therapeutics Sales by Region (2027-2032) & (US$ Million) Table 49. Global Cancer Pain Therapeutics Sales Market Share in Value by Region (2027-2032) Table 50. Global Cancer Pain Therapeutics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 51. Global Cancer Pain Therapeutics Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Cancer Pain Therapeutics Sales by Application (2021-2026) & (k units) Table 53. Global Cancer Pain Therapeutics Sales Market Share in Volume by Application (2021-2026) Table 54. Global Cancer Pain Therapeutics Sales by Application (2021-2026) & (US$ Million) Table 55. Global Cancer Pain Therapeutics Sales Market Share in Value by Application (2021-2026) Table 56. Global Cancer Pain Therapeutics Price by Application (2021-2026) & (US$/unit) Table 57. Global Cancer Pain Therapeutics Sales by Application (2027-2032) & (k units) Table 58. Global Cancer Pain Therapeutics Sales Market Share in Volume by Application (2027-2032) Table 59. Global Cancer Pain Therapeutics Sales by Application (2027-2032) & (US$ Million) Table 60. Global Cancer Pain Therapeutics Sales Market Share in Value by Application (2027-2032) Table 61. Global Cancer Pain Therapeutics Price by Application (2027-2032) & (US$/unit) Table 62. North America Cancer Pain Therapeutics Sales by Application (2021-2026) & (k units) Table 63. North America Cancer Pain Therapeutics Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Cancer Pain Therapeutics Sales by Application (2021-2026) & (k units) Table 65. Europe Cancer Pain Therapeutics Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Cancer Pain Therapeutics Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Cancer Pain Therapeutics Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Cancer Pain Therapeutics Sales by Application (2021-2026) & (k units) Table 69. Latin America Cancer Pain Therapeutics Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Cancer Pain Therapeutics Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Cancer Pain Therapeutics Sales by Application (2021-2026) & (US$ Million) Table 72. BioDelivery Science Company Information Table 73. BioDelivery Science Business Overview Table 74. BioDelivery Science Cancer Pain Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. BioDelivery Science Cancer Pain Therapeutics Product Portfolio Table 76. BioDelivery Science Recent Development Table 77. Grunenthal Group Company Information Table 78. Grunenthal Group Business Overview Table 79. Grunenthal Group Cancer Pain Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Grunenthal Group Cancer Pain Therapeutics Product Portfolio Table 81. Grunenthal Group Recent Development Table 82. GW Pharmaceuticals Company Information Table 83. GW Pharmaceuticals Business Overview Table 84. GW Pharmaceuticals Cancer Pain Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. GW Pharmaceuticals Cancer Pain Therapeutics Product Portfolio Table 86. GW Pharmaceuticals Recent Development Table 87. Meda Pharmaceuticals Company Information Table 88. Meda Pharmaceuticals Business Overview Table 89. Meda Pharmaceuticals Cancer Pain Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Meda Pharmaceuticals Cancer Pain Therapeutics Product Portfolio Table 91. Meda Pharmaceuticals Recent Development Table 92. Orexo Company Information Table 93. Orexo Business Overview Table 94. Orexo Cancer Pain Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Orexo Cancer Pain Therapeutics Product Portfolio Table 96. Orexo Recent Development Table 97. ProStrakan Group Company Information Table 98. ProStrakan Group Business Overview Table 99. ProStrakan Group Cancer Pain Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. ProStrakan Group Cancer Pain Therapeutics Product Portfolio Table 101. ProStrakan Group Recent Development Table 102. WEX Pharmaceuticals Company Information Table 103. WEX Pharmaceuticals Business Overview Table 104. WEX Pharmaceuticals Cancer Pain Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. WEX Pharmaceuticals Cancer Pain Therapeutics Product Portfolio Table 106. WEX Pharmaceuticals Recent Development Table 107. Eli-Lilly Company Information Table 108. Eli-Lilly Business Overview Table 109. Eli-Lilly Cancer Pain Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Eli-Lilly Cancer Pain Therapeutics Product Portfolio Table 111. Eli-Lilly Recent Development Table 112. Johnson＆Johnson Company Information Table 113. Johnson＆Johnson Business Overview Table 114. Johnson＆Johnson Cancer Pain Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Johnson＆Johnson Cancer Pain Therapeutics Product Portfolio Table 116. Johnson＆Johnson Recent Development Table 117. Sanofi Company Information Table 118. Sanofi Business Overview Table 119. Sanofi Cancer Pain Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. Sanofi Cancer Pain Therapeutics Product Portfolio Table 121. Sanofi Recent Development Table 122. Teva pharmaceuticals Company Information Table 123. Teva pharmaceuticals Business Overview Table 124. Teva pharmaceuticals Cancer Pain Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 125. Teva pharmaceuticals Cancer Pain Therapeutics Product Portfolio Table 126. Teva pharmaceuticals Recent Development Table 127. North America Cancer Pain Therapeutics Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 128. North America Cancer Pain Therapeutics Sales by Country (2021-2026) & (k units) Table 129. North America Cancer Pain Therapeutics Sales Market Share by Country (2021-2026) Table 130. North America Cancer Pain Therapeutics Sales Forecast by Country (2027-2032) & (k units) Table 131. North America Cancer Pain Therapeutics Sales Market Share Forecast by Country (2027-2032) Table 132. North America Cancer Pain Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. North America Cancer Pain Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 134. North America Cancer Pain Therapeutics Market Share by Country (2021-2026) Table 135. North America Cancer Pain Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. North America Cancer Pain Therapeutics Market Share Forecast by Country (2027-2032) Table 137. Europe Cancer Pain Therapeutics Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 138. Europe Cancer Pain Therapeutics Sales by Country (2021-2026) & (k units) Table 139. Europe Cancer Pain Therapeutics Sales Market Share by Country (2021-2026) Table 140. Europe Cancer Pain Therapeutics Sales Forecast by Country (2027-2032) & (k units) Table 141. Europe Cancer Pain Therapeutics Sales Market Share Forecast by Country (2027-2032) Table 142. Europe Cancer Pain Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Europe Cancer Pain Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 144. Europe Cancer Pain Therapeutics Market Share by Country (2021-2026) Table 145. Europe Cancer Pain Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Europe Cancer Pain Therapeutics Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Cancer Pain Therapeutics Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Cancer Pain Therapeutics Sales by Country (2021-2026) & (k units) Table 149. Asia-Pacific Cancer Pain Therapeutics Sales Market Share by Country (2021-2026) Table 150. Asia-Pacific Cancer Pain Therapeutics Sales Forecast by Country (2027-2032) & (k units) Table 151. Asia-Pacific Cancer Pain Therapeutics Sales Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Cancer Pain Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Cancer Pain Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 154. Asia-Pacific Cancer Pain Therapeutics Market Share by Country (2021-2026) Table 155. Asia-Pacific Cancer Pain Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Asia-Pacific Cancer Pain Therapeutics Market Share Forecast by Country (2027-2032) Table 157. Latin America Cancer Pain Therapeutics Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 158. Latin America Cancer Pain Therapeutics Sales by Country (2021-2026) & (k units) Table 159. Latin America Cancer Pain Therapeutics Sales Market Share by Country (2021-2026) Table 160. Latin America Cancer Pain Therapeutics Sales Forecast by Country (2027-2032) & (k units) Table 161. Latin America Cancer Pain Therapeutics Sales Market Share Forecast by Country (2027-2032) Table 162. Latin America Cancer Pain Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Latin America Cancer Pain Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 164. Latin America Cancer Pain Therapeutics Market Share by Country (2021-2026) Table 165. Latin America Cancer Pain Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Latin America Cancer Pain Therapeutics Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Cancer Pain Therapeutics Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Cancer Pain Therapeutics Sales by Country (2021-2026) & (k units) Table 169. Middle East and Africa Cancer Pain Therapeutics Sales Market Share by Country (2021-2026) Table 170. Middle East and Africa Cancer Pain Therapeutics Sales Forecast by Country (2027-2032) & (k units) Table 171. Middle East and Africa Cancer Pain Therapeutics Sales Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Cancer Pain Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Cancer Pain Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 174. Middle East and Africa Cancer Pain Therapeutics Market Share by Country (2021-2026) Table 175. Middle East and Africa Cancer Pain Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Middle East and Africa Cancer Pain Therapeutics Market Share Forecast by Country (2027-2032) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Cancer Pain Therapeutics Distributors List Table 180. Cancer Pain Therapeutics Customers List Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Cancer Pain Therapeutics Image Figure 2. Global Cancer Pain Therapeutics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cancer Pain Therapeutics Market Size (2021-2032) & (US$ Million) Figure 4. Global Cancer Pain Therapeutics Sales (2021-2032) & (k units) Figure 5. Opioids Image Figure 6. Global Opioids Sales YoY Growth (2021-2032) & (k units) Figure 7. Non-Steroidal Anti-Inflammatory Drugs Image Figure 8. Global Non-Steroidal Anti-Inflammatory Drugs Sales YoY Growth (2021-2032) & (k units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Cancer Pain Therapeutics Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Cancer Pain Therapeutics Market Share by Type 2025 VS 2032 Figure 13. North America Cancer Pain Therapeutics Sales Market Share in Volume by Type in 2025 Figure 14. North America Cancer Pain Therapeutics Sales Market Share in Value by Type in 2025 Figure 15. Europe Cancer Pain Therapeutics Sales Market Share in Volume by Type in 2025 Figure 16. Europe Cancer Pain Therapeutics Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Cancer Pain Therapeutics Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Cancer Pain Therapeutics Sales Market Share in Value by Type in 2025 Figure 19. Latin America Cancer Pain Therapeutics Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Cancer Pain Therapeutics Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Cancer Pain Therapeutics Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Cancer Pain Therapeutics Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Cancer Pain Therapeutics Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hormone Therapy Image Figure 26. Global Hormone Therapy Sales YoY Growth (2021-2032) & (k units) Figure 27. Chemotherapy Image Figure 28. Global Chemotherapy Sales YoY Growth (2021-2032) & (k units) Figure 29. Radiotherapy Image Figure 30. Global Radiotherapy Sales YoY Growth (2021-2032) & (k units) Figure 31. Paracetamol Treatment-Related Immunotherapy Image Figure 32. Global Paracetamol Treatment-Related Immunotherapy Sales YoY Growth (2021-2032) & (k units) Figure 33. Global Cancer Pain Therapeutics Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Cancer Pain Therapeutics Market Share by Application 2025 VS 2032 Figure 35. North America Cancer Pain Therapeutics Sales Market Share in Volume by Application in 2025 Figure 36. North America Cancer Pain Therapeutics Sales Market Share in Value by Application in 2025 Figure 37. Europe Cancer Pain Therapeutics Sales Market Share in Volume by Application in 2025 Figure 38. Europe Cancer Pain Therapeutics Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Cancer Pain Therapeutics Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Cancer Pain Therapeutics Sales Market Share in Value by Application in 2025 Figure 41. Latin America Cancer Pain Therapeutics Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Cancer Pain Therapeutics Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Cancer Pain Therapeutics Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Cancer Pain Therapeutics Sales Market Share in Value by Application in 2025 Figure 45. North America Cancer Pain Therapeutics Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America Cancer Pain Therapeutics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Cancer Pain Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Cancer Pain Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Cancer Pain Therapeutics Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe Cancer Pain Therapeutics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Cancer Pain Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Cancer Pain Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Cancer Pain Therapeutics Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific Cancer Pain Therapeutics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Cancer Pain Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Cancer Pain Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Cancer Pain Therapeutics Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America Cancer Pain Therapeutics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Cancer Pain Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Cancer Pain Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Cancer Pain Therapeutics Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa Cancer Pain Therapeutics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Cancer Pain Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Cancer Pain Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Cancer Pain Therapeutics Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Cancer Pain Therapeutics Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Opioids
  • Non-Steroidal Anti-Inflammatory Drugs
  • Others
Applications
  • Hormone Therapy
  • Chemotherapy
  • Radiotherapy
  • Paracetamol Treatment-Related Immunotherapy
Companies covered
  • BioDelivery Science
  • Grunenthal Group
  • GW Pharmaceuticals
  • Meda Pharmaceuticals
  • Orexo
  • ProStrakan Group
  • WEX Pharmaceuticals
  • Eli-Lilly
  • Johnson＆Johnson
  • Sanofi
  • Teva pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cancer Pain Therapeutics Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cancer Pain Therapeutics Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cancer Pain Therapeutics Market by Type
  6. 1.3.1 Opioids
  7. 1.3.2 Non-Steroidal Anti-Inflammatory Drugs
  8. 1.3.3 Others
  9. 1.4 Global Cancer Pain Therapeutics Market Size by Type
  10. 1.4.1 Global Cancer Pain Therapeutics Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Cancer Pain Therapeutics Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Cancer Pain Therapeutics Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Cancer Pain Therapeutics Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Cancer Pain Therapeutics Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Cancer Pain Therapeutics Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Cancer Pain Therapeutics Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Cancer Pain Therapeutics Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cancer Pain Therapeutics Industry Trends
  2. 2.2 Cancer Pain Therapeutics Industry Drivers
  3. 2.3 Cancer Pain Therapeutics Industry Opportunities and Challenges
  4. 2.4 Cancer Pain Therapeutics Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cancer Pain Therapeutics Revenue (2021-2026)
  2. 3.2 Global Top Players by Cancer Pain Therapeutics Sales (2021-2026)
  3. 3.3 Global Top Players by Cancer Pain Therapeutics Price (2021-2026)
  4. 3.4 Global Cancer Pain Therapeutics Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cancer Pain Therapeutics Major Company Production Sites & Headquarters
  6. 3.6 Global Cancer Pain Therapeutics Company, Product Type & Application
  7. 3.7 Global Cancer Pain Therapeutics Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cancer Pain Therapeutics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cancer Pain Therapeutics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cancer Pain Therapeutics Tier 1, Tier 2, and Tier 3
4 Cancer Pain Therapeutics Regional Status and Outlook
  1. 4.1 Global Cancer Pain Therapeutics Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cancer Pain Therapeutics Historic Market Size by Region
  3. 4.2.1 Global Cancer Pain Therapeutics Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cancer Pain Therapeutics Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cancer Pain Therapeutics Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cancer Pain Therapeutics Forecasted Market Size by Region
  7. 4.3.1 Global Cancer Pain Therapeutics Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cancer Pain Therapeutics Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cancer Pain Therapeutics Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cancer Pain Therapeutics by Application
  1. 5.1 Cancer Pain Therapeutics Market by Application
  2. 5.1.1 Hormone Therapy
  3. 5.1.2 Chemotherapy
  4. 5.1.3 Radiotherapy
  5. 5.1.4 Paracetamol Treatment-Related Immunotherapy
  6. 5.2 Global Cancer Pain Therapeutics Market Size by Application
  7. 5.2.1 Global Cancer Pain Therapeutics Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Cancer Pain Therapeutics Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Cancer Pain Therapeutics Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Cancer Pain Therapeutics Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Cancer Pain Therapeutics Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Cancer Pain Therapeutics Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Cancer Pain Therapeutics Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Cancer Pain Therapeutics Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 BioDelivery Science
  2. 6.1.1 BioDelivery Science Company Information
  3. 6.1.2 BioDelivery Science Business Overview
  4. 6.1.3 BioDelivery Science Cancer Pain Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 BioDelivery Science Cancer Pain Therapeutics Product Portfolio
  6. 6.1.5 BioDelivery Science Recent Developments
  7. 6.2 Grunenthal Group
  8. 6.2.1 Grunenthal Group Company Information
  9. 6.2.2 Grunenthal Group Business Overview
  10. 6.2.3 Grunenthal Group Cancer Pain Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Grunenthal Group Cancer Pain Therapeutics Product Portfolio
  12. 6.2.5 Grunenthal Group Recent Developments
  13. 6.3 GW Pharmaceuticals
  14. 6.3.1 GW Pharmaceuticals Company Information
  15. 6.3.2 GW Pharmaceuticals Business Overview
  16. 6.3.3 GW Pharmaceuticals Cancer Pain Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GW Pharmaceuticals Cancer Pain Therapeutics Product Portfolio
  18. 6.3.5 GW Pharmaceuticals Recent Developments
  19. 6.4 Meda Pharmaceuticals
  20. 6.4.1 Meda Pharmaceuticals Company Information
  21. 6.4.2 Meda Pharmaceuticals Business Overview
  22. 6.4.3 Meda Pharmaceuticals Cancer Pain Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Meda Pharmaceuticals Cancer Pain Therapeutics Product Portfolio
  24. 6.4.5 Meda Pharmaceuticals Recent Developments
  25. 6.5 Orexo
  26. 6.5.1 Orexo Company Information
  27. 6.5.2 Orexo Business Overview
  28. 6.5.3 Orexo Cancer Pain Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Orexo Cancer Pain Therapeutics Product Portfolio
  30. 6.5.5 Orexo Recent Developments
  31. 6.6 ProStrakan Group
  32. 6.6.1 ProStrakan Group Company Information
  33. 6.6.2 ProStrakan Group Business Overview
  34. 6.6.3 ProStrakan Group Cancer Pain Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 ProStrakan Group Cancer Pain Therapeutics Product Portfolio
  36. 6.6.5 ProStrakan Group Recent Developments
  37. 6.7 WEX Pharmaceuticals
  38. 6.7.1 WEX Pharmaceuticals Company Information
  39. 6.7.2 WEX Pharmaceuticals Business Overview
  40. 6.7.3 WEX Pharmaceuticals Cancer Pain Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 WEX Pharmaceuticals Cancer Pain Therapeutics Product Portfolio
  42. 6.7.5 WEX Pharmaceuticals Recent Developments
  43. 6.8 Eli-Lilly
  44. 6.8.1 Eli-Lilly Company Information
  45. 6.8.2 Eli-Lilly Business Overview
  46. 6.8.3 Eli-Lilly Cancer Pain Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Eli-Lilly Cancer Pain Therapeutics Product Portfolio
  48. 6.8.5 Eli-Lilly Recent Developments
  49. 6.9 Johnson＆Johnson
  50. 6.9.1 Johnson＆Johnson Company Information
  51. 6.9.2 Johnson＆Johnson Business Overview
  52. 6.9.3 Johnson＆Johnson Cancer Pain Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Johnson＆Johnson Cancer Pain Therapeutics Product Portfolio
  54. 6.9.5 Johnson＆Johnson Recent Developments
  55. 6.10 Sanofi
  56. 6.10.1 Sanofi Company Information
  57. 6.10.2 Sanofi Business Overview
  58. 6.10.3 Sanofi Cancer Pain Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Sanofi Cancer Pain Therapeutics Product Portfolio
  60. 6.10.5 Sanofi Recent Developments
  61. 6.11 Teva pharmaceuticals
  62. 6.11.1 Teva pharmaceuticals Company Information
  63. 6.11.2 Teva pharmaceuticals Business Overview
  64. 6.11.3 Teva pharmaceuticals Cancer Pain Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Teva pharmaceuticals Cancer Pain Therapeutics Product Portfolio
  66. 6.11.5 Teva pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Cancer Pain Therapeutics Sales by Country
  2. 7.1.1 North America Cancer Pain Therapeutics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cancer Pain Therapeutics Sales by Country (2021-2026)
  4. 7.1.3 North America Cancer Pain Therapeutics Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cancer Pain Therapeutics Market Size by Country
  6. 7.2.1 North America Cancer Pain Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cancer Pain Therapeutics Market Size by Country (2021-2026)
  8. 7.2.3 North America Cancer Pain Therapeutics Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cancer Pain Therapeutics Sales by Country
  2. 8.1.1 Europe Cancer Pain Therapeutics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cancer Pain Therapeutics Sales by Country (2021-2026)
  4. 8.1.3 Europe Cancer Pain Therapeutics Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cancer Pain Therapeutics Market Size by Country
  6. 8.2.1 Europe Cancer Pain Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cancer Pain Therapeutics Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cancer Pain Therapeutics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cancer Pain Therapeutics Sales by Country
  2. 9.1.1 Asia-Pacific Cancer Pain Therapeutics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cancer Pain Therapeutics Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cancer Pain Therapeutics Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cancer Pain Therapeutics Market Size by Country
  6. 9.2.1 Asia-Pacific Cancer Pain Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cancer Pain Therapeutics Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cancer Pain Therapeutics Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cancer Pain Therapeutics Sales by Country
  2. 10.1.1 South America Cancer Pain Therapeutics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cancer Pain Therapeutics Sales by Country (2021-2026)
  4. 10.1.3 South America Cancer Pain Therapeutics Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cancer Pain Therapeutics Market Size by Country
  6. 10.2.1 South America Cancer Pain Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cancer Pain Therapeutics Market Size by Country (2021-2026)
  8. 10.2.3 South America Cancer Pain Therapeutics Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cancer Pain Therapeutics Sales by Country
  2. 11.1.1 Middle East and Africa Cancer Pain Therapeutics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cancer Pain Therapeutics Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cancer Pain Therapeutics Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cancer Pain Therapeutics Market Size by Country
  6. 11.2.1 Middle East and Africa Cancer Pain Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cancer Pain Therapeutics Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cancer Pain Therapeutics Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cancer Pain Therapeutics Value Chain Analysis
  2. 12.1.1 Cancer Pain Therapeutics Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cancer Pain Therapeutics Production Mode & Process
  7. 12.2 Cancer Pain Therapeutics Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cancer Pain Therapeutics Distributors
  10. 12.2.3 Cancer Pain Therapeutics Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst